Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
FOCIS Advanced Course in Basic and Clinical Immunology
AAN: Annual Meeting On Demand Encore: Treatment Optimization for Relapsing MS
Association between beta-interferon exposure and hospital events in multiple sclerosis.
Free MED IQ Live CME Event on Multiple Sclerosis Nov 22nd
Pathogenic aquaporin-4 reactive T cells are sufficient to induce mouse model of neuromyelitis optica.
Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging.
Neuroimmunomodulation by allogeneic seminal vesicle fluid in CNS is sex-independent.
Aubagio® significantly reduced risk of new clinical relapse or MRI lesion in multiple sclerosis study
Anti-inflammatory dimethylfumarate: a potential new therapy for asthma?
Dendritic cell, monocyte and T cell activation and response to glatiramer acetate in multiple sclerosis.
Acute disseminated encephalomyelitis in 228 patients: A retrospective, multicenter US study.
Gene-expression signatures: biomarkers toward diagnosing multiple sclerosis.
The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group.
Interferon beta-1b
Neuroimmunology: Phase II trial demonstrates efficacy of erythropoietin in optic neuritis.
Contribution of different relapse phenotypes to disability in multiple sclerosis.
Antibody to α4 integrin suppresses natural killer cells infiltration in central nervous system in experimental autoimmune encephalomyelitis.
Effect of smoking on multiple sclerosis: a meta-analysis.
Microglia in health and disease.
European Commission approves Genzyme’s multiple sclerosis treatment Lemtrada™ (alemtuzumab)
Immune Tolerance and Autoimmune Disease Conference
Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis.
The employment concerns of Americans with multiple sclerosis: Perspectives from a national sample.
Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action.
You-Gui pills promote nerve regeneration by regulating netrin1, DCC and Rho family GTPases RhoA, Racl, Cdc42 in C57BL/6 mice with experimental autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
63
64
65
66
67
68
69
70
71
…
next ›
last »